Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Adenocarcinoma Metastatic

Explore clinical trials studying Pancreatic Adenocarcinoma Metastatic. Study availability and eligibility vary by location and protocol.

20 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Adenocarcinoma Metastatic trial results

Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07562152

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations
  • City of Hope Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 30 locations
View Trial Details
Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07491445

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

NCT07621718

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Recruiting

Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

NCT07377045

Conditions
Pancreatic Adenocarcinoma Metastatic
Locations
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
  • Hospital Universitario Vall d'Hebron (VHIO) Barcelona, Spain
  • Hospital Universitario Donostia Donostia / San Sebastian, Spain
  • ICO- Hospitalet Catalan Institute of Oncology L'Hospitalet de Llobregat, Spain
View Trial Details
Recruiting

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

NCT07284277

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • Clínica Universidad de Navarra Pamplona, Navarre, Spain
  • Hospital Universitario de Cruces Barakaldo, Vizcaya, Spain
  • Hospital de Galdakao Galdakao, Vizcaya, Spain
  • Fundación Jiménez-Díaz Madrid, Spain
View Trial Details

Related conditions